MedPath

江苏淮安双鹤药业有限责任公司

Ownership
-
Established
2001-11-26
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

40

NMPA:40

Drug Approvals

Puerarin and Glucose Injection

Product Name
麦瑞缘
Approval Number
国药准字H20010550
Approval Date
Jun 22, 2020
NMPA

Glucose and Sodium Chloride Injection

Product Name
葡萄糖氯化钠注射液
Approval Number
国药准字H32022435
Approval Date
Jun 22, 2020
NMPA

Dextran 40 Glucose Injection

Product Name
右旋糖酐40葡萄糖注射液
Approval Number
国药准字H32022423
Approval Date
Jun 22, 2020
NMPA

Compound Sodium Chloride Injection

Product Name
复方氯化钠注射液
Approval Number
国药准字H32020474
Approval Date
Jun 22, 2020
NMPA

Glucose Injection

Product Name
葡萄糖注射液
Approval Number
国药准字H20163387
Approval Date
Jun 22, 2020
NMPA

Dextran 40 Glucose Injection

Product Name
右旋糖酐40葡萄糖注射液
Approval Number
国药准字H32022422
Approval Date
Jun 22, 2020
NMPA

Sodium Chloride Injection

Product Name
氯化钠注射液
Approval Number
国药准字H32023235
Approval Date
Jun 22, 2020
NMPA

Mannitol Injection

Product Name
甘露醇注射液
Approval Number
国药准字H32020117
Approval Date
Jun 22, 2020
NMPA

Sodium Chloride Injection

Product Name
氯化钠注射液
Approval Number
国药准字H32023237
Approval Date
Jun 22, 2020
NMPA

Dextran 40 Glucose Injection

Product Name
右旋糖酐40葡萄糖注射液
Approval Number
国药准字H32022424
Approval Date
Jun 22, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.